Description: Alpa Laboratories Limited engages in the manufacture and sale of pharmaceutical finished dosage forms in India. The company offers ethical, generic, and over the counter pharmaceutical products in various finished dosage forms, including injections, tablets, capsules, eye and ear drops, creams, gels, and ointments for human and veterinary use. It also provides drugs in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, antiprotozoals, and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular drugs; anti-diabetics; nutritional supplements; psychotropic drugs; and skin care preparations, as well as ear and eye care preparations. The company sells its products through distributors, retail chemists, retail pharmacy stores, and hospitals. It also exports its products to South and Central America, Africa, and Asia, Russia, Ukraine, Kazakhstan, and internationally. The company was founded in 1967 and is based in Indore, India.
Home Page: www.alpalabs.in
33/2 Pigdamber
Indore,
453446
India
Phone:
91 73 1429 4567
Officers
| Name | Title |
|---|---|
| Mr. Mahendra Singh Chawla | Chairman of the Board |
| Mr. Paresh Chawla | MD & Director |
| Mr. Bakulesh Chandulal Shah | Chief Financial Officer |
| Ms. Swati Bagh | Company Secretary & Compliance Officer |
| Mr. Pravin C. Shah | Executive Director |
| Mr. Shitul Shah | Additional Whole Time Director |
| Mr. Vitthal Kothana | Executive Director |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 12.7947 |
| Price-to-Book MRQ: | 1.5429 |
| Price-to-Sales TTM: | 2.3084 |
| IPO Date: | 2007-08-06 |
| Fiscal Year End: | March |
| Full Time Employees: | 410 |